Biogen Inc. buy Royal Bank of Canada
Start price
05.03.24
/
50%
€201.60
Target price
05.03.25
€334.73
Performance (%)
-34.05%
End price
06.03.25
€132.95
Summary
This prediction ended on 06.03.25 with a price of €132.95. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. performed very badly with a performance of -34.05%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 4.345% | 4.345% | -9.716% |
| iShares Core DAX® | 1.343% | -1.493% | 26.063% |
| iShares Nasdaq 100 | -1.235% | 0.457% | 8.184% |
| iShares Nikkei 225® | -2.386% | 4.669% | 17.678% |
| iShares S&P 500 | -0.486% | 0.800% | 3.258% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $364.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten